LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Anakinra utilization in refractory pediatric CAR T-cell associated toxicities

Photo by nci from unsplash

Caroline Diorio,* Anant Vatsayan,* Aimee C. Talleur, Colleen Annesley, Jennifer J. Jaroscak, Haneen Shalabi, Amanda K. Ombrello, Michelle Hudspeth, Shannon L. Maude, Rebecca A. Gardner, and Nirali N. Shah Pediatric… Click to show full abstract

Caroline Diorio,* Anant Vatsayan,* Aimee C. Talleur, Colleen Annesley, Jennifer J. Jaroscak, Haneen Shalabi, Amanda K. Ombrello, Michelle Hudspeth, Shannon L. Maude, Rebecca A. Gardner, and Nirali N. Shah Pediatric Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; Division of BMT, Children’s National Hospital, Washington, DC; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN; Department of Pediatrics, Seattle Children’s Hospital, Seattle, WA; Pediatric Hematology/Oncology, Medical University of South Carolina, Charleston, SC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

Keywords: oncology; refractory pediatric; anakinra utilization; utilization refractory; car cell; pediatric car

Journal Title: Blood Advances
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.